Page last updated: 2024-09-05

dabigatran and Hypercoagulability

dabigatran has been researched along with Hypercoagulability in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (4.44)	29.6817
2010's	38 (84.44)	24.3611
2020's	5 (11.11)	2.80

Authors

Authors	Studies
Boudot de la Motte, M; Daval, M; Deschamps, L; Deschamps, R; Diallo, IM; Nilles, C; Poillon, G	1
Albisetti, M; Bomgaars, L; Brandão, LR; Chalmers, E; Felgenhauer, J; Halton, J; Luciani, M; Lvova, O; Mitchell, LG; Saracco, P; Simetzberger, M; Sun, Z; Tartakovsky, I	1
Ashley, J; Badve, SV; Battistella, M; Bota, S; Garg, AX; Harel, Z; Jun, M; Manuel, D; Mavrakanas, T; McArthur, E; Molnar, AO; Rhodes, E; Sood, MM; Tanuseputro, P; Wells, P	1
Davis, KA; Valanejad, SM	1
Cho, HJ; Choi, HY; Choi, S; Jang, HJ; Jang, SS; Jeon, S; Kim, DE; Kim, H; Kim, J; Kim, K; Kim, YD; Kwon, IC; Lee, KY; Lee, SK; Nahrendorf, M; Ryu, WS; Schellingerhout, D	1
Fischer, AM; Godier, A; Martin, AC; Mauge, L; Smadja, DM	1
Debasse, M; Feyen, L; Jacquemin, M; Peerlinck, K; Schoeters, J; Toelen, J; Van Horenbeeck, I; Vanassche, T; Vanlinthout, I; Verhamme, P	1
Al-Samkari, H; Connors, JM	1
Kairov, GT; Kotlovskaya, LY; Solovev, MA; Udut, VV	1
Curnow, J; Favaloro, EJ; Mohammed, S; Pasalic, L	1
Ahmad, Y; Lip, GY	1
Chana, F; Llau, JV; Marco, P; Zamorano, JL	1
Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V	1
Adelmeijer, J; Arshad, F; Blokzijl, H; Lisman, T; Porte, RJ; Potze, W; van den Berg, AP	1
González-Rico, MA; Juan-García, I; Miguel-Carrasco, A; Puchades-Montesa, MJ; Ramos-Tomás, C; Ribés-Cruz, JJ; Solís-Salguero, MA; Tejedor-Alonso, S; Tomás-Simó, P; Torregrosa-Maicas, I; Zambrano-Esteves, P	1
Laroche, JP	1
Fenger-Eriksen, C; Grove, EL; Münster, AM	1
Curnow, J; Joseph, J; McLintock, C; McRae, S; Nandurkar, H; Tran, H; Wood, P; Young, L	1
Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE	1
Bnouhanna, W; Cho, TH; Davenas, C; Derex, L; Farghali, A; Mechtouff, L; Nighoghossian, N; Ritzenthaler, T	1
Lane, DA; Wood, K	1
Karbyshev, IA; Petrikov, AS; Shoikhet, YN; Vyatkin, DA; Zakharchenko, KK	1
Alla, F; Billionnet, C; Blotière, PO; Bouillon, K; Maura, G; Ricordeau, P; Zureik, M	1
Buitrago, F; Capilla Lozano, F; Gallego Fuentes, R; Rodríguez Pérez, L	1
Collins, J; Fraeman, K; Reynolds, MW; Schnee, J; Schwartzman, E; Siu, K; Villines, TC	1
Bartels, DB; Bykov, K; Huybrechts, K; Schneeweiss, S; Seeger, JD; Zint, K	1
Crijns, HJ; De Boer, HC; De Jong, AM; Kamphuisen, PW; Kuiper, M; Lau, DH; Linz, D; Lumeij, S; Maass, AH; Rienstra, M; Schotten, U; Spronk, HM; Ten Cate, H; Van Gelder, IC; van Hunnik, A; van Zonneveld, AJ; Verheule, S; Zeemering, S	1
Berrouschot, J; Eschenfelder, CC; Hogh, T; Stoll, A	1
Eriksson, H; Feuring, M; Fraessdorf, M; Goldhaber, SZ; Kakkar, A; Kreuzer, J; Schellong, S; Schueler, E; Schulman, S	1
Goralczyk, T; Undas, A	1
Conard, J; Horellou, MH; Samama, MM	1
Cerbone, AM; Coppola, A; Franchini, M; Ruosi, C; Tufano, A	1
Ajzenberg, N; Dumont, B; Faille, D	1
Arya, R; Patel, JP; Roberts, LN	1
Heidinger, K; Kemkes-Matthes, B	1
Masjuan, J	1
Gil Núñez, A	1
Vivancos Mora, J; Ximénez-Carrillo Rico, A; Zapata Wainberg, G	1
Ataullakhanov, FI; Panteleev, MA; Sinauridze, EI	1
Finsterer, J; Rakusan, S; Stöllberger, C; Wimpissinger, FT	1
Ansell, J; Mantha, S	1
Larsen, TB; Rasmussen, LH; Skjøth, F	1
Dumenil, AS; Galbois, A; Lillo-Le Louët, A; Offenstadt, G; Samama, MM; Soufir, L; Wolf, M	1
Harenberg, J; Marx, S; Wehling, M	1
Eikelboom, JW; Hirsh, J; O'Donnell, M	1

Reviews

15 review(s) available for dabigatran and Hypercoagulability

Article	Year
Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders. The Annals of pharmacotherapy, 2021, Volume: 55, Issue:7 Topics: Administration, Oral; Anticoagulants; Dabigatran; Hemorrhage; Humans; Rivaroxaban; Thrombophilia; Venous Thromboembolism	2021
[State of the art: Direct oral anticoagulants and transfusion]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2017, Volume: 24, Issue:3 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Arginine; Blood Coagulation Factors; Blood Transfusion; Dabigatran; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Hemostatics; Humans; Piperazines; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Stroke; Thrombophilia	2017
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation. Contributions to nephrology, 2013, Volume: 179 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Comorbidity; Dabigatran; Disease Management; Embolism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Intracranial Embolism; Male; Morpholines; Patient Selection; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Warfarin	2013
[New clinical perspectives in the management of oral direct anticoagulant agents]. Medicina clinica, 2014, Feb-20, Volume: 142, Issue:4 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Elective Surgical Procedures; Emergencies; Factor Xa Inhibitors; Hemorrhage; Humans; Kidney Diseases; Morpholines; Orthopedic Procedures; Postoperative Complications; Premedication; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk; Rivaroxaban; Thiophenes; Thrombophilia; Vitamin K	2014
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities. European journal of internal medicine, 2014, Volume: 25, Issue:1 Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin	2014
New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications. Acta anaesthesiologica Scandinavica, 2014, Volume: 58, Issue:6 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism; Thrombophilia	2014
Preventing postsurgical venous thromboembolism: pharmacological approaches. Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:3 Topics: Aged; Anticoagulants; Antithrombins; Arthroscopy; Bariatric Surgery; Benzimidazoles; Blood Coagulation Disorders, Inherited; Dabigatran; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Kidney; Knee; Laparoscopy; Morpholines; Neoplasms; Orthopedic Procedures; Polysaccharides; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thrombophilia; Venous Thromboembolism	2011
[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future]. Medecine sciences : M/S, 2011, Volume: 27, Issue:5 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Approval; Drug Monitoring; Factor Xa Inhibitors; Fibrinolytic Agents; Forecasting; France; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Thrombophilia; Venous Thromboembolism	2011
Anticoagulating obese patients in the modern era. British journal of haematology, 2011, Volume: 155, Issue:2 Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Humans; Morpholines; Multicenter Studies as Topic; Obesity; Polysaccharides; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Venous Thrombosis; Warfarin	2011
[New anticoagulants. Characteristics, monitoring and management of bleeding]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2011, Volume: 106, Issue:3 Topics: Administration, Oral; Antithrombins; Arthroplasty, Replacement, Hip; Atrial Fibrillation; Benzimidazoles; Blood Coagulation Tests; Critical Care; Dabigatran; Drug Approval; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombophilia; Vitamin K	2011
[Prevention of cardioembolic stroke]. Neurologia (Barcelona, Spain), 2012, Volume: 27 Suppl 1 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fibrinolytic Agents; Heart Diseases; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Multicenter Studies as Topic; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Single-Blind Method; Thrombophilia; Vitamin K	2012
[Clinical management of the new anticoagulants]. Neurologia (Barcelona, Spain), 2012, Volume: 27 Suppl 1 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Monitoring; Drugs, Investigational; Hemorrhage; Humans; Morpholines; Multicenter Studies as Topic; Patient Care Planning; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombophilia; Vitamin K	2012
Anticoagulant therapy: basic principles, classic approaches and recent developments. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2012, Volume: 23, Issue:6 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Factor Xa; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudins; Humans; Platelet Aggregation Inhibitors; Thrombin; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamin K; Warfarin	2012
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation. Thrombosis and haemostasis, 2012, Volume: 108, Issue:3 Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Heart Valve Diseases; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Morpholines; Multicenter Studies as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Vitamin K; Warfarin	2012
Beyond unfractionated heparin and warfarin: current and future advances. Circulation, 2007, Jul-31, Volume: 116, Issue:5 Topics: Angina, Unstable; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Brain Ischemia; Clinical Trials as Topic; Coumarins; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Forecasting; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Morpholines; Myocardial Infarction; Peptide Fragments; Polysaccharides; Prothrombin; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Thrombosis; Warfarin	2007

Trials

2 trial(s) available for dabigatran and Hypercoagulability

Article	Year
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia. Blood advances, 2022, 11-22, Volume: 6, Issue:22 Topics: Child; Dabigatran; Humans; Protein C Deficiency; Recurrence; Risk Factors; Secondary Prevention; Thrombophilia; United States; Venous Thromboembolism	2022
Features of Pharmacodynamics of the Anticoagulant Dabigatran in Secondary Thrombophilia. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:9_suppl Topics: Adult; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Thrombophilia	2018

Other Studies

28 other study(ies) available for dabigatran and Hypercoagulability

Article	Year
IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case report. Journal of neuroimmunology, 2021, 11-15, Volume: 360 Topics: Abducens Nerve Diseases; Adrenal Cortex Hormones; Adult; Dabigatran; Female; Humans; Immunoglobulin G4-Related Disease; Lateral Sinus Thrombosis; Lung; Magnetic Resonance Imaging; Mastoidectomy; Mastoiditis; Meningitis; Neuroimaging; Rituximab; Thrombophilia; Tomography, X-Ray Computed; Venous Thrombosis	2021
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 76, Issue:3 Topics: Aged; Aged, 80 and over; Antithrombins; Brain Ischemia; Cause of Death; Comorbidity; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Male; Mortality; Myocardial Infarction; Myocardial Revascularization; Ontario; Procedures and Techniques Utilization; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Retrospective Studies; Rivaroxaban; Thrombophilia; Vitamin K	2020
Short-Term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State. Annals of neurology, 2021, Volume: 89, Issue:3 Topics: Aged; Aged, 80 and over; Animals; Antithrombins; Arachidonic Acid; Aspirin; Carotid Artery Thrombosis; Cerebral Infarction; Chlorides; Computed Tomography Angiography; Dabigatran; Deprescriptions; Factor Xa Inhibitors; Female; Ferric Compounds; Humans; Ischemic Stroke; Magnetic Resonance Angiography; Male; Mean Platelet Volume; Mice; Noxae; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Pyrazoles; Pyridones; Rivaroxaban; Severity of Illness Index; Substance Withdrawal Syndrome; Thrombin; Thrombophilia; X-Ray Microtomography	2021
The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays. International journal of laboratory hematology, 2018, Volume: 40, Issue:4 Topics: Adsorption; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation Tests; Dabigatran; Drug Interactions; Humans; Thrombophilia	2018
Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability. American journal of hematology, 2018, Volume: 93, Issue:6 Topics: Adult; Anticoagulants; Antithrombins; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Fondaparinux; Humans; Lung Neoplasms; Male; Recurrence; Thrombophilia; Thrombosis; Venous Thromboembolism	2018
Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives. Pathology, 2019, Volume: 51, Issue:3 Topics: Anticoagulants; Antiphospholipid Syndrome; Blood Coagulation; Blood Coagulation Tests; Dabigatran; False Negative Reactions; False Positive Reactions; Humans; Lupus Coagulation Inhibitor; Prothrombin Time; Rivaroxaban; Thrombophilia	2019
Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis. British journal of haematology, 2013, Volume: 163, Issue:5 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Diagnostic Tests, Routine; Drug Monitoring; Factor Xa Inhibitors; False Negative Reactions; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Liver Cirrhosis; Male; Middle Aged; Morpholines; Polysaccharides; Prothrombin; Rivaroxaban; Sensitivity and Specificity; Thiophenes; Thrombophilia	2013
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6 Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, Type 2; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension; Metabolic Clearance Rate; Renal Dialysis; Renal Insufficiency, Chronic; Thrombophilia; Urinary Tract Infections	2013
[New anticoagulants: stop or more?]. Journal des maladies vasculaires, 2014, Volume: 39, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Anticoagulants; Antidotes; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Dissent and Disputes; Dose-Response Relationship, Drug; Drug Approval; Drug Industry; Drugs, Investigational; France; Humans; International Normalized Ratio; Lobbying; Pharmacovigilance; Thrombophilia	2014
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis. Internal medicine journal, 2014, Volume: 44, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Blood Loss, Surgical; Contraindications; Dabigatran; Drug Interactions; Drug Monitoring; Drug Substitution; Elective Surgical Procedures; Emergencies; Hematoma, Epidural, Spinal; Hemorrhage; Humans; Kidney Diseases; Liver Diseases; Morpholines; Patient Selection; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombophilia	2014
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thrombosis and haemostasis, 2014, Volume: 112, Issue:5 Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin	2014
Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke. Revue neurologique, 2015, Volume: 171, Issue:8-9 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Length of Stay; Male; Pilot Projects; Radiography; Recombinant Proteins; Recurrence; Retrospective Studies; Rivaroxaban; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator	2015
Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation. Circulation, 2015, Apr-21, Volume: 131, Issue:16 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Interactions; Drug Monitoring; Drug Substitution; Female; Hemorrhage; Humans; Kidney Diseases; Kidney Function Tests; Male; Morpholines; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombophilia	2015
[Use of dabigatran etexilate for treatment of deep vein thrombosis and pulmonary artery thromboembolism]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2015, Volume: 21, Issue:2 Topics: Adult; Angiography; Benzimidazoles; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Echocardiography; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Prodrugs; Prospective Studies; Pulmonary Embolism; Pyridines; Russia; Thrombophilia; Treatment Outcome; Venous Thrombosis	2015
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study. Circulation, 2015, Sep-29, Volume: 132, Issue:13 Topics: Adolescent; Adult; Aged; Anticoagulants; Antithrombins; Arterial Occlusive Diseases; Atrial Fibrillation; Dabigatran; Databases, Factual; Factor Xa Inhibitors; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Middle Aged; Risk; Rivaroxaban; Thromboembolism; Thrombophilia; Vitamin K; Warfarin; Young Adult	2015
[New oral anticoagulants in patients with atrial fibrillation in a urban health center]. Medicina clinica, 2016, Mar-18, Volume: 146, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Utilization; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thrombophilia; Urban Health Services	2016
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Disease-Free Survival; Drug Evaluation; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Insurance Coverage; Kaplan-Meier Estimate; Male; Middle Aged; Military Personnel; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult	2015
Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Drug Evaluation; Embolism; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Insurance Coverage; Male; Middle Aged; Myocardial Infarction; Polypharmacy; Propensity Score; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult	2015
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. European heart journal, 2017, 01-01, Volume: 38, Issue:1 Topics: Analysis of Variance; Animals; Antithrombins; Atrial Fibrillation; Cell Proliferation; Dabigatran; Female; Fibrinolytic Agents; Fibroblasts; Fibrosis; Goats; Heart Atria; Indazoles; Mice, Transgenic; Nadroparin; Peptide Hydrolases; Pyrroles; Quinazolines; Rats; Receptors, Thrombin; Thrombin; Thrombophilia; Urea	2017
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab. Stroke, 2016, Volume: 47, Issue:7 Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Atrial Fibrillation; Brain Ischemia; Dabigatran; Diabetes Mellitus, Type 2; Humans; Hypertension; Infarction, Middle Cerebral Artery; Male; Paresis; Recombinant Proteins; Recovery of Function; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator	2016
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™. Vascular medicine (London, England), 2016, Volume: 21, Issue:6 Topics: Acute Disease; Adult; Aged; Anticoagulants; Antithrombins; Dabigatran; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Thrombophilia; Time Factors; Treatment Outcome; Venous Thromboembolism; Warfarin	2016
Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2017, Volume: 28, Issue:6 Topics: Adult; Anticoagulants; Dabigatran; Female; Humans; Male; Medication Adherence; Middle Aged; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Thrombophilia; Venous Thromboembolism; Young Adult	2017
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians]. Journal des maladies vasculaires, 2009, Volume: 34, Issue:5 Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Benzimidazoles; Blood Loss, Surgical; Cesarean Section; Contraindications; Dabigatran; Europe; Evidence-Based Medicine; Female; Fetus; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Morpholines; Polysaccharides; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Pyridines; Rivaroxaban; Societies, Medical; Thiophenes; Thrombophilia; United States; Uterine Hemorrhage; Venous Thromboembolism; Warfarin	2009
[Prevention of stroke in atrial fibrillation]. Neurologia (Barcelona, Spain), 2012, Volume: 27 Suppl 1 Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Heart Rate; Humans; International Normalized Ratio; Intracranial Embolism; Myocardial Contraction; Risk Factors; Stroke; Thrombophilia	2012
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention. Thrombosis and haemostasis, 2012, Volume: 108, Issue:3 Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Bone Neoplasms; Brain Ischemia; Comorbidity; Dabigatran; Hematuria; Humans; Kidney Failure, Chronic; Leuprolide; Male; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Thrombophilia; Urinary Retention	2012
Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation. Thrombosis and haemostasis, 2012, Volume: 108, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Female; Humans; Male; Morpholines; Multicenter Studies as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombophilia	2012
Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Thrombosis and haemostasis, 2012, Volume: 108, Issue:3 Topics: Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Colectomy; Combined Modality Therapy; Dabigatran; Emergencies; Erythrocyte Transfusion; Factor VIIa; Fatal Outcome; Female; Hemostatics; Humans; Kidney Diseases; Male; Plasma; Postoperative Hemorrhage; Recombinant Proteins; Renal Dialysis; Resuscitation; Thrombophilia	2012
Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next? Thrombosis and haemostasis, 2012, Volume: 108, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Female; Humans; Male; Morpholines; Multicenter Studies as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombophilia	2012